Extracellular Matrix Tissue Patch for Septal Defect Repair in Pediatric Cardiac Surgery: A Single-Center Experience

Area of Science:

• Biomaterials Science
• Pediatric Cardiology
• Regenerative Medicine

Background:

• Decellularized extracellular matrix (ECM) patches offer a promising alternative to traditional materials in pediatric cardiac surgery.
• Clinical evidence for ECM scaffold use in septal defect repair is currently limited.
• This study addresses the need for data on ECM patch efficacy in pediatric congenital heart defect repair.

Purpose of the Study:

• To evaluate the applicability and early clinical outcomes of decellularized extracellular matrix (ECM) scaffolds in pediatric septal defect repair.
• To analyze perioperative variables and postoperative complications associated with ECM patch usage.
• To assess the safety and effectiveness of ECM patches across different types of septal defects.

Main Methods:

• Single-center retrospective study utilizing national cardiac surgery registry data.
• Inclusion of 72 procedures in 68 pediatric patients (10 days to 16 years old).
• Analysis of early postoperative outcomes, including complications, reoperations, and mortality.

Main Results:

• Low postoperative complication rate (1.4%) and mortality (2.9%) observed.
• Continuous renal replacement therapy was required in 8.8% of patients.
• No significant differences in outcomes were found between atrial and ventricular septal defect repair groups.

Conclusions:

• Decellularized extracellular matrix (ECM) patches represent a safe and effective option for pediatric septal defect repair.
• ECM scaffolds demonstrate satisfactory early outcomes and low complication rates.
• ECM patches are suitable for various congenital heart defects requiring septal repair.